$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
治疗套细胞淋巴瘤新药阿卡替尼的效果
2025-10-19 11:44:20
Check Details
利妥昔单抗的说明书
2025-10-19 11:44:20
Check Details
利妥昔单抗多久有效果
2025-10-19 11:44:20
Check Details
利妥昔单抗多少钱一瓶
2025-10-19 11:44:20
Check Details
利妥昔单抗多少钱一支
2025-10-19 11:44:20
Check Details
利妥昔单抗何时上市
2025-10-19 11:44:20
Check Details
利妥昔单抗和美罗华一样吗
2025-10-19 11:44:20
Check Details
利妥昔单抗获批上市了吗
2025-10-19 11:44:20
Check Details
利妥昔单抗进医保了吗
2025-10-19 11:44:20
Check Details
利妥昔单抗可以报销吗
2025-10-19 11:44:20
Check Details
利妥昔单抗是靶向药吗
2025-10-19 11:44:20
Check Details
利妥昔单抗是不是靶向药
2025-10-19 11:44:20
Check Details
1
2
...
1223
1224
1225
1226
1227
1228
1229
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
2
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
3
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
4
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
5
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
6
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
7
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
8
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
9
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
10
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
11
Eltrombopag Administration Timing and Alternative Therapy Guide
12
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings